Meeting
2023 ASCO Annual Meeting
EpCAM CAR T (IMC001) for the treatment of advanced GI cancers.
Presenter
Guoqiang Ai, PhD
Suzhou Immunofoco Biotechnology Co., Ltd
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer - Advanced/Metastatic Disease
Clinical Trial Registration Number
NCT05028933
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4034)
DOI
10.1200/JCO.2023.41.16_suppl.4034
Abstract #
4034
Poster Bd #
355
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2024 ASCO Annual Meeting
Phase I study of C-CAR031, a GPC3-specific TGFβRIIDN armored autologous CAR-T, in patients with advanced hepatocellular carcinoma (HCC).
Speaker: Qi Zhang, MD
Videos & Slides
2021 ASCO Annual Meeting
Phase I trial of fourth-generation chimeric antigen receptor T-cells targeting glypican-3 for advanced hepatocellular carcinoma.
Speaker: Weijia Fang, MD
Speaker: Panel Discussion
Videos & Slides
2017 ASCO Annual Meeting
Autologous HER2 CAR T cells after lymphodepletion for advanced Sarcoma: results from a Phase I clinical trial
Speaker: Meenakshi G. Hegde, MBBS